TC-1827
TC-1827 is an orally active, selective agonist of the α 4 β 2 nicotinic receptors.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
TC-1827 is an orally active, selective agonist of the α 4 β 2 nicotinic receptors. Administration of TC-1827 improved memory and learning in a variety of rodents and increased long-term potentiation in hippocampal slices. In addition, the compound was without significant cardiovascular side effects, except for a small, transient rise in arterial blood pressure.
The pro-cognitive effects of TC-1827 last much longer than the short half-life (0.2–1.0 hours) would suggest.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1362878272 under CC BY-SA 4.0; modifications have been made.